MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
  • XML
    134.22 Kb
  • HTML
    119.92 Kb
Add to My Favorites
You must be logged in to use this functionality
Loading full text...

Full text loading...

1. Radoshevich L,, Bierne H,, Ribet D,, Cossart P. 2012. The new microbiology: a conference at the Institut de France. C R Biol 335:514518.
2. Woese CR,, Fox GE. 1977. Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc Natl Acad Sci USA 74:50885090.
3. Ciccarelli FD,, Doerks T,, von Mering C,, Creevey CJ,, Snel B,, Bork P. 2006. Toward automatic reconstruction of a highly resolved tree of life. Science 311:12831287.
4. Medini D,, Serruto D,, Parkhill J,, Relman DA,, Donati C,, Moxon R,, Falkow S,, Rappuoli R. 2008. Microbiology in the post genomic era. Nat Rev Microbiol 6:419430.
5. Jensen RB,, Wang SC,, Shapiro L. 2002. Dynamic localization of proteins and DNA during a bacterial cell cycle. Nat Rev Mol Cell Biol 3:167176.
6. Gitai Z. 2005. The new bacterial cell biology: moving parts and cellular architecture. Cell 120:577586.
7. Cabeen MT,, Jacobs-Wagner C. 2007. Skin and bones: the bacterial cytoskeleton, cell wall, and cell morphogenesis. J Cell Biol 179:381387.
8. Cabeen MT,, Jacobs-Wagner C. 2010. The bacterial cytoskeleton. Annu Rev Genet 44:365392.
9. Toro E,, Shapiro L. 2010. Bacterial chromosome organization and segregation. Cold Spring Harb Perspect Biol 2:a000349.
10. Campos M,, Jacobs-Wagner C. 2013. Cellular organization of the transfer of genetic information. Curr Opin Microbiol 16:171176.
11. Ozyamak E,, Kollman JM,, Komeili A. 2013. Bacterial actins and their diversity. Biochemistry 52:69286939.
12. Laoux G,, Jacobs-Wagner C. 2014. How do bacteria localize proteins to the cell pole? J Cell Sci 127:1119.
13. Jacob F,, Monod J. 1961. Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol 3:318356.
14. Roth A,, Breaker RR. 2009. The structural and functional diversity of metabolite‑binding riboswitches. Annu Rev Biochem 78:305309.
15. Gottesman S,, Storz G. 2011. Bacterial small regulators: versatile roles and rapidly evolving variations. Cold Spring Harb Perspect Biol 3:pii:a003798. doi:10.1101/cshperspect.a003798. http://dx.doi.org/10.1101/cshperspect.a003798
16. Storz G,, Vogel J,, Wasserman KM. 2011. Regulation by small RNAs in bacteria: expanding frontiers. Mol Cell 43:880891.
17. Breaker RR. 2012. Riboswitches and the RNA world. Cold Spring Harb Perspect Biol 4:pii:a003566. doi:1101/cshperpect.a003566. http://dx.doi.org/1101/cshperpect.a003566
18. Calderi I,, Chao Y,, Romby P,, Vogel J. 2013. RNA-mediated regulation in pathogenic bacteria. Cold Spring Harb Perspect Biol 3:a010298. doi:10.1101/cshperpect.a010298. http://dx.doi.org/10.1101/cshperpect.a010298
19. Sesto N,, Wurtzel O,, Archambaud C,, Sorek R,, Cossart P. 2013. The excludon: a new concept in bacterial anti-sense RNA mediated gene regulation. Nat Rev Microbiol 11:7582.
20. Mellin JR,, Tiensuu T,, Becavin C,, Gouin E,, Johansson J,, Cossart P. 2013. A riboswitch-regulated anti-sense RNA in Listeria monocytogenes. Proc Natl Acad Sci USA 110:1313213137.
21. Barrangou R,, Fremaux C,, Deveau H,, Richards M,, Boyaval P,, Moineau S,, Romero DA,, Horvath P. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:17091712.
22. Deltcheva E,, Chylinski K,, Sharma S,, Gonzales K,, Chao Y,, Pirzada ZA,, Eckert MR,, Vogel J,, Charpentier E. 2011. CRISPR RNA maturation by trans-encoded small RNA and host factor RNAse III. Nature 471:602607.
23. Jinek M,, Chylinski K,, Fonfara I,, Hauer M,, Doudna JA,, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816821.
24. Jiang W,, Bikard D,, Cox D,, Zhang F,, Maraffini LA. 2013. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nature Biotech 31:233239.
25. Dupuis ME,, Villion M,, Magadan AH,, Moineau S. 2013. CRISPR-Cas and restriction-modification systems are compatible and increase phage resistance. Nat Commun 4:2087.
26. Hsu P,, Lander E,, Zhang F. 2014. Development and applications of CRISPR-Cas9 for genome editing. Cell 157:12621278.
27. Selle K,, Barrangou R. 2015. Harnessing CRISPR-Cas systems for bacterial genome editing. Trends Microbiol 23:225232.
28. Kiani S,, Chavez A,, Tuttle M,, Hall RN,, Chari R,, Ter-Ovanesyan D,, Qian J,, Pruitt BW,, Beal J,, Vora S,, Buchthal J,, Kowal EJ,, Ebrahimkhani MR,, Collins JJ,, Weiss R,, Church G. 2015. Cas9 gRNA engineering for genome editing, activation and repression. Nat Methods 11:10511054.
29. Sockett E,, Lambert C. 2004. Bdellovibrio as therapeutic agents: a predatory renaissance. Nat Rev Microbiol 2:669674.
30. Dublanchet A,, Fruciano E. 2008. Brève histoire de la phagothérapie. A short history of phage therapy. Med Maladies Infect 38:415420.
31. Debarbieux L,, Dublanchet A,, Patay O. 2008. Infection bactérienne: quelle place pour la phagothérapie. Med Maladies Infect 38:407409.
32. Makarov V, , et al. 2009. Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. Science 8:801804.
33. Cotter P,, Ross RP,, Hill C. 2013. Bacteriocins—a viable alternative to antibiotics. Nat Rev Microbiol 11:95105.
34. World Health Organization. 2014. WHO's first global report on antibiotic resistance reveals serious, worldwide threat to public health. April 2014. http://www.who.int/mediacentre/news/releases/2014/amr-report/en/ [Premier rapport de l'OMS sur la résistance aux antibiotiques: une menace grave d'ampleur mondiale, avril 2014, http://www.who.int/mediacentre/ news/releases/2014/amr‑report/fr/].
35. Institut Pasteur. 2014. Antibiotiques: quand les bactéries font de la résistance. (Dossier.) Lettre de l'Institut Pasteur 85. https://www.pasteur.fr/sites/default/files/rubrique_nous_soutenir/lip/lip85-resistance_aux_antibiotiques-institut-pasteur.pdf (2014).
36. Lambert C,, Sockett RE. 2013. Nucleases in Bdellovibrio bacteriovorus contribute towards efficient self-biofilm formation and eradication of preformed prey biofilms. FEMS Microbiol Lett 340:109116.
37. Allen H,, Trachsel J,, Looft T,, Casey T. 2014. Finding alternatives to antibiotics. Ann NY Acad Sci 1323:91100.
38. Baker S. 2015. A return to the pre-antimicrobial era? The effects of antimicrobial resitance will be felt most acutely in lower income countries. Science 347:1064.
39. Ling L,, Schenider T,, Peoples A,, Spoering A,, Engels I,, Conlon BP,, Mueller A,, Schäberle TF,, Hughes DE,, Epstein S,, Jones M,, Lazarides L,, Steadman V,, Cohen DR,, Felix C,, Fetterman KA,, Millet W,, Nitti AG,, Zullo AM,, Chen C,, Lewis K. 2015. A new antibiotic kills pathogens without detectable resistance. Nature 517:455459.
40. Davies DG,, Parsek MR,, Pearson JP,, Iglewski BH,, Costerton JW,, Greenberg EP. 1998. Involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280:295298.
41. O'Toole G,, Kaplan HB,, Kolter R. 2000. Biofilm formation as microbial development. Annu Rev Microbiol 18:4979.
42. Stanley NR,, Lazazzera BA. 2004. Environmental signals and regulatory pathways that influence biofilm formation. Mol Microbiol 52:917924.
43. Kolter R,, Greenberg EP. 2006. Microbial sciences: the superficial life of microbes. Nature 441:300302.
44. Römling U,, Galperin MY,, Gomlesky M. 2013. Cyclic di-GMP: the first 25 years of a universal bacterial second messenger. Microbiol Mol Biol Rev 77:152.
45. Bassler BL,, Losick R. 2006. Bacterially speaking. Cell 125:237246.
46. Duan F,, March JC. 2008. Interrupting Vibrio cholerae infection of human epithelial cells with engineered commensal bacterial signaling. Biotechnol Bioeng 101:128134.
47. Duan F,, March JC. 2010. Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model. Proc Natl Acad Sci USA 107:1126011264.
48. Schuster M,, Sexton DJ,, Diggle SP,, Greenberg EP. 2013. Acyl-homoserine lactone quorum sensing: from evolution to application. Annu Rev Microbiol 67:4363.
49. Schwarz S,, West TE,, Boyer F,, Chiang WC,, Carl MA,, Hood RD,, Rohmer L,, Tolker-Nielsen T,, Skerret S,, Mougous J. 2010. Burkholderia type VI secretion systems have distinct roles in eukaryotic and bacterial cell interactions. PLoS Pathog 6:e10011068.
50. Hibbing ME,, Fuqua C,, Parsek M,, Peterson SB. 2010. Bacterial competition: surviving and thriving in the microbiological jungle. Nat Rev Microbiol 8:1525.
51. Hayes CS,, Aoki SK,, Low DA. 2010. Bacterial contact-dependent delivery systems. Annu Rev Genet 44:7190.
52. Aoki S,, Poole SJ,, Hayes C,, Low D. 2011. Toxin on a stick. Modular CDI toxin delivery systems play roles in bacterial competition. Virulence 2:356359.
53. Russell AB,, Hood R,, Bui NK,, LeRoux M,, Vollmer W,, Mougous J. 2011. Type VI secretion delivers bacteriolytic effectors to target cells. Nature 475:343347.
54. Basler M,, Ho BT,, Mekalanos J. 2013. Tit for tat: type VI secretion system counterattack during bacterial cell‑cell interactions. Cell 152:884894.
55. Ho BT,, Dong TG,, Mekalanos JJ. 2014. A view to a kill: the bacterial type VI secretion system. Cell Host Microbe 15:921.
56. Etayash H,, Azmi S,, Dangeti R,, Kaur K. 2015. Peptide bacteriocins. Curr Top Med Chem 16:220241.
57. McFall-Ngai M,, Montgomery MK. 1990. The anatomy and morphology of the adult bacterial light organ of Euprymna scolopes (Cephalopoda: Sepiolidae). Biol Bull 179:332339.
58. McFall-Ngai M,, Heath-Heckman EA,, Gillette AA,, Peyer SM,, Harvie EA. 2012. The secret languages of coevolved symbioses: insight from the Euprymna scolopes–Vibrio fischeri symbiosis. Semin Immunol 24:38.
59. McFall-Ngai M,, Hadfield MG,, Bosch TC,, Carey HV,, Domazet-Loso TX. 2013. Animals in a bacterial world, a new imperative for the life sciences. Proc Natl Acad Sci USA 110:32293236.
60. David LA,, Maurice CF,, Carmody RN,, Gootenberg DB,, Button JE,, Wolfe BE,, Ling AV,, Devlin AS,, Varma Y,, Fischbach MA,, Biddinger MA,, Dutton EJ,, Turnbaugh PJ. 2014. Diet rapidly and reproducibly alters the human microbiome. Nature 505:559563.
61. Yurist-Doutsch S,, Arrieta MC,, Vogt SL,, Finlay BB. 2014. Gastrointestinal microbiota-mediated control of enteric pathogens. Annu Rev Genet 48:361382.
62. Brune A. 2014. Symbiotic digestion of lignocellulose in termite guts. Nature Rev Microbiol 12:168180.
63. Belkaid Y,, Segre J. 2014. Dialogue between skin microbiota and immunity. Science 346:954959.
64. Knights D,, Ward T,, McKinlay CE,, Miller H,, Gonzalez A,, McDonald D,, Knight R. 2014. Rethinking “enterotypes.” Cell Host Microbe 16:433437.
65. Vogt SL,, Pena-Diaz J,, Finlay BB. 2015. Chemical communication in the gut: effects of microbiota-generated metabolites on gastrointestinal bacterial pathogens. Anaerobe 34:106115.
66. Derrien M,, Van Hylckama Vlieg JET. 2015. Fate, activity and impact of ingested bacteria within the human gut. Trends Microbiol 23:354366.
67. Thompson JA,, Oliveira RA,, Djukovic A,, Ubeda C,, Xavier KB. 2015. Manipulation of the quorum sensing signal AI‑2 affects the antibiotic-treated gut microbiota. Cell Rep 10:18611871.
68. Asher G,, Sassone-Corsi P. 2015. Time for food: the intimate interplay between nutrition, metabolism and the circadian clock. Cell 161:8492.
69. Yano J,, Yu K,, Donalsdson GP,, Shastri GG,, Phoebe A,, Ma L,, Nagler CR,, Ismagilov RF,, Mazmanian SK,, Hsiao E. 2015. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161:264276.
70. Schnupf P,, Gaboriau-Routhiau V,, Gros M,, Friedman R,, Moya-Nilges M,, Nigro G,, Cerf-Bensussan N,, Sansonetti PJ. 2015. Growth and host interaction of mouse segmented filamentous bacteria in vitro. Nature 520:99103.
71. Sender R,, Fuchs S,, Milo R. 2016. Are we really outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164:337340.
72. Jones KM,, Kobayashi H,, Davies BW,, Taga ME,, Walker GC. 2007. How rhizobial symbionts invade plants: the Sinorhizobium-Medicago model. Nat Rev Microbiol 5:619633.
73. Kondorosi E,, Mergaert P,, Kereszt A. 2013. A paradigm for endosymbiotic life: cell differentiation of Rhizobium bacteria provoked by host plants. Annu Rev Microbiol 67:611628.
74. Bulgarelli D,, Schlaeppi K,, Spaepen S,, Ver Loren van Themaat E,, Schulze-Lefert P. 2013. Structure and functions of the bacterial microbiota of plants. Annu Rev Plant 64:807838.
75. Lai CY,, Baumann L,, Baumann P. 1994. Amplification of TrpEG: adaptation of Buchnera aphidicola to an endosymbiotic association with aphids. Proc Natl Acad Sci USA 91:38193823.
76. Douglas AE. 1998. Nutritional interactions in insect-microbial symbiosies: aphids and their symbiotic Buchnera. Annu Rev Entomol 43:1737.
77. Moran NA,, Baumann P. 2000. Bacterial endosymbionts in animals. Curr Opin Microbiol 2:270275.
78. Gil R,, Sabater-Munoz B,, Latorre A,, Silva FJ,, Moya A. 2002. Extreme genome reduction in Buchnera spp.: toward the minimal genome needed for symbiotic life. Proc Natl Acad Sci USA 99:44544458.
79. Sassera D,, Beninati T,, Bandi C,, Bouman EAP,, Sacchi L,, Fabbi M,, Lo N. 2006. Candidatus Midichloria mitochondrii, an endosymbiont of the tick Ixodes ricinus with a unique intramitochondrial lifestyle. Internat J Systemat Evol Microbiol 56:25352540.
80. Moya A,, Pereto J,, Gil R,, Latorr A. 2008. Learning how to live together: genomic insights into prokaryote-animal symbioses. Nature Rev Genet 8:218229.
81. Engelstadter J,, Hurst GDD. 2009. The ecology and evolution of microbes that manipulate host reproduction. Annu Rev Ecol Evol Syst 40:127149.
82. Shigenobu S,, Wilson ACC. 2011. Genomic revelations of a mutualism: the pea aphid and its obligate symbiont. Cell Mol Life Sci 68:12971309.
83. Bouchery T,, Lefoulon E,, Karadjian G,, Nieguitsila A,, Martin C. 2012. The symbiotic role of Wolbachia in onchocercidae and its impact on filariasis. Clin Microbiol Infect 19:131140.
84. Scott AL,, Ghedin E,, Nutman TB,, McReynolds LA,, Poole CB,, Slatko BE,, Foster JM. 2012. Filarial and Wolbachia genomics. Parasite Immunol 34:121129.
85. Schulz F,, Horn M. 2015. Intranuclear bacteria: inside the cellular control center of eukaryotes. Trends Cell Biol 25:339346.
86. Shea JE,, Hensel M,, Gleeson C,, Holden DW. 1996. Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc Natl Acad Sci USA 93:25932597.
87. Sansonetti PJ. 2006. The bacterial weaponry: lessons from Shigella. Ann NY Acad Sci 1072:307312.
88. Sussman M. (ed.). 2014. Molecular Medical Microbiology, 2nd ed. Academic Press, New York, NY.
89. Cornelis GR,, Wolf-Watz H. 1997. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol Microbiol 23:861867.
90. Cole ST, , et al. 2001. Massive gene decay in the leprosy bacillus. Nature 409:10071011.
91. Cole ST, , et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537544.
92. Cossart P. 2011. Illuminating the landscape of host-pathogen interactions with the bacterium Listeria monocytogenes. Proc Natl Acad Sci USA 108:1948419491.
93. Sperandio B,, Fischer N,, Sansonetti PJ. 2015. Mucosal physical and chemical innate barriers: lessons from microbial evasion strategies. Semin Immunol 27:111118.
94. Isberg RR,, Falkow S. 1985. A single genetic locus encoded by Yersinia pseudo-tuberculosis permits invasion of cultured animal cells by Escherichia coli K12. Nature 317:262264.
95. Galan JE,, Curtiss R III. 1989. Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc Natl Acad Sci USA 86:63836387.
96. Cossart P,, Boquet P,, Normark S,, Rappuoli R. 1996. Cellular microbiology emerging. Science 271:315316.
97. Finlay BB,, Cossart P. 1997. Exploitation of host cell functions by bacterial pathogens. Science 276:718725.
98. Cossart P,, Sansonetti PJS. 2004. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 304:242248.
99. Galan JE,, Cossart P. 2004. Host-pathogen interactions: a diversity of themes, a variety of molecular machines. Curr Opin Microbiol 8:13.
100. Cossart P,, Roy CR. 2010. Manipulation of host membrane machinery by bacterial pathogens. Curr Opin Cell Biol 22:547554.
101. Hubber A,, Roy CR. 2010. Modulation of host cell function by Legionella pneumophila type IV effectors. Annu Rev Cell Dev Biol 26:261283.
102. Pizarro-Cerdá J,, Kühbacher A,, Cossart P. 2012. Entry of Listeria in mammalian cells: an updated view. Cold Spring Harb Perspect Med 2(11):pii: a010009. doi:10.1101/cshperspect.a010009 http://dx.doi.org/10.1101/cshperspect.a010009
103. Bierne H,, Hamon M,, Cossart P. 2012. Epigenetics and bacterial infections. Cold Spring Harb Perspect Med 2(12):a010272. doi:10.1101/cshperspect.a010272 http://dx.doi.org/10.1101/cshperspect.a010272
104. Puhar A,, Sansonetti PJ. 2014. Type III secretion system. Curr Biol 24:R8491.
105. Helaine S,, Cheverton AM,, Watson KG,, Faure LM,, Matthews SA,, Holden DW. 2014. Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science 343:204208.
106. Rolando M,, Buchrieser C. 2014. Legionella pneumophila type IV effectors hijack the transcription and translation machinery of the host cell. Trends Cell Biol 24:771778.
107. Arena ET,, Campbell-Valois FX,, Tinevez JY,, Nigro G,, Sachse M,, Moya-Nilges M,, Nothelfer K,, Marteyn B,, Shorte SL,, Sansonetti PJ. 2015. Bioimage analysis of Shigella infection reveals targeting of colonic crypts. Proc Natl Acad Sci USA 112:32823290.
108. Spanò S,, Gao X,, Hannemann S,, Lara-Tejero M,, Galán JE. 2016. A bacterial pathogen targets a host Rab-family GTPase defense pathway with a GAP. Cell Host Microbe 19:216226.
109. Vallet-Gely I,, Lemaitre B,, Boccard F. 2008. Bacterial strategies to overcome insect defences. Nature Rev Microbiol 6:302313.
110. Nielsen-Leroux C,, Gaudriault S,, Ramarao N,, Lereclus D,, Givaudan A. 2012. How the insect pathogen bacteria Bacillus thuringiensis and Xenorhabdus/Photorhabdus occupy their hosts. Curr Opin Microbiol 15:220231.
111. Mole BM,, Baltrus DA,, Dangl JL,, Grant SR. 2007. Global virulence regulation networks in phytopathogenic bacteria. Trends Microbiol 15:363371.
112. Hogenhout SA,, Oshima K,, Ammar E,, Kakizawa S,, Kingdom H,, Namba S. 2008. Phytoplasmas: bacteria that manipulate plants and insects. Mol Plant Pathol 9:403423.
113. Kay S,, Bonas U. 2009. How Xanthomonas type III effectors manipulate the host plant. Curr Opin Microbiol 12:3743.
114. Sugio A,, MacLean A,, Kingdom H,, Grieve VM,, Manimekalia R,, Hogenhout S. 2011. Diverse targets of Phytoplasma effectors: from plant development to defense against insects. Annu Rev Phytopathol 49:175195.
115. Dou D,, Zhou JM. 2012. Phytopathogen effectors subverting host immunity: different foes, similar battleground. Cell Host Microbe 12:484495.
116. Deslandes L,, Rivas S. 2012. Catch me if you can: bacterial effectors and plant targets. Trends Plant Sci 17:644655.
117. Casanova J-L,, Abel L. 2002. Genetic dissection of immunity to bacteria: the human model. Annu Rev Immunol 20:581620.
118. Lam-Yuk-Tseung S,, Gros P. 2003. Genetic control of susceptibility to bacterial infections in mouse models. Cell Microbiol 5:299313.
119. Quintana-Murci L,, Alcais A,, Abel L,, Casanova J-L. 2007. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat Immunol 8:11651171.
120. Casanova J-L,, Abel L. 2013. The genetic theory of infectious diseases: a brief history and selected illustrations. Annu Rev Genomics Hum Genet 14:215243.
121. Dussoix D,, Arber W. 1962. Host specificity of DNA produced by Escherichia coli. J Mol Biol 5:3749.
122. Saiki R,, Gelfand D,, Stoffel S,, Scharf S,, Higuchi R,, Horn G,, Mullis K,, Erlich H. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487491.
123. Oesterhelt D,, Stoekenius W. 1971. Rhodopsin-like protein from the purple membrane of Halobacterium halobium. Nat New Biol 233:149152.
124. Williams S,, Deisseroth K. 2013. Optogenetics. Proc Natl Acad Sci USA 110:16287.
125. Deisseroth K. 2011. Optogenetics. Nat Methods 8:2629.
126. Lafountaine JS,, Fathe K,, Smyth HDC. 2015. Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs and CRISPR/Cas9. Int J Pharmaceut 494:180194.
127. Kocks C,, Gouin E,, Tabouret M,, Berche P,, Ohayon H,, Cossart P. 1992. Listeria monocytogenes-induced actin assembly requires the actA gene, a surface protein. Cell 68:521531.
128. Ridley AJ,, Hall A. 1992. The small GTP-binding protein rho regulates the assembly of focal adhesion and actin stress fibers in response to growth factors. Cell 70:389399.
129. Bierne H,, Cossart P. 2012. When bacteria target the nucleus: the emerging family of nucleomodulins. Cell Microbiol 14:622633.
130. Morelli L. 2014. Yogurt, living cultures and gut health. Am J Clin Nutr 99:1248S1250S.
131. Mackowiak PA. 2013. Recycling Metchnikoff: probiotics, the intestinal microbiome and the quest for long life. Front Publ Health 1:13.
132. Sassone-Corsi M,, Raffatelu M. 2015. No vacancy: how beneficial microbes cooperate with immunity to provide colonization resistance to pathogens. J Immunol 194:40814087.
133. Nami Y,, Haghshenas B,, Abdullah N,, Barzagari A,, Radiah D,, Rosli R,, Khostoushahi AY. 2015. Probiotics or antibiotics: future challenges in medicine. J Med Microbiol 64:137146.
134. Borody TJ,, Khoruts A. 2011. Fecal microbiota transplantation and emerging applications. Nature Rev Gastroenterol Hepatol 9:8896.
135. Smits LP,, Bouter KE,, De Vos WM,, Borody TJ,, Niewdorp M. 2013. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 145:946953.
136. Engel P,, Moran NA. 2013. The gut microbiota of insects—diversity in structure and function. FEMS Microbiol Rev 37:699735.
137. Hedge S,, Rasgon JL,, Hughes GL. 2015. The microbiome modulates arbovirus transmission in mosquitoes. Curr Opin Virol 15:97102.
138. Sander J,, Joung JK. 2014. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotech 32:347355.
139. Vogel G. 2015. Bioethics. Embryo engineering alarm. Science 347:1301.
140. Baltimore D, , et al 2015. A prudent path forward for genomic engineering and germline modification: a framework for open discourse on the use of CRISPR-Cas9 technology to manipulate the human genome is urgently needed. Science 348:3637.
141. Rath D,, Amlinger L,, Rath A,, Lundgren M. 2015. The CRISPR-Cas immune system: biology, mechanisms and applications. Biochimie 117:119128.
142. Bosley K, , et al 2015. CRISPR germ line engineering—the community speaks. Nat Biotech 33:478486.
143. Malyshev D,, Dhami K,, Lavergne T,, Chen T,, Dai N,, Foster JM,, Correa I Jr,, Romesberg FE. 2014. A semi synthetic organism with an expanded genetic alphabet. Nature 509:385388.
144. Breitling R,, Takano E. 2015. Synthetic biology advances for pharmaceutical production. Curr Opin Biotechnol 35:4651.
145. Liu W,, Stewart CN. 2015. Plant synthetic biology. Trends Plant Sci 20:309317.
146. Hutchison CA III, , et al. 2016. Design and synthesis of a minimal bacterial genome. Science 351:aad6253. doi:10.1126/science.aad6253. http://dx.doi.org/10.1126/science.aad6253
147. Van Frankenhuysen K. 2009. Insecticidal activity of Bacillus thuringiensis crystal proteins. J Invertebr Pathol 101:116.
148. Pardo-López L,, Soberón M,, Bravo A. 2013. Bacillus thuringiensis insecticidal three-domain Cry toxins: mode of action, insect resistance and consequences for crop protection. FEMS Microbiol Rev 37:322.
149. Bravo A,, Gómez I,, Porta H,, García-Gómez BI,, Rodriguez-Almazan C,, Pardo L,, Soberón M. 2013. Evolution of Bacillus thuringiensis Cry toxins insecticidal activity. Microb Biotechnol 6:1726.
150. Elleuch J,, Tounsi S,, Belguith Ben Hassen N,, Lacrois MN,, Chandre F,, Jaoua S,, Zghal RZ. 2015. Characterization of novel Bacillus thuringiensis isolates against Aedes aegypti (Diptera: Culicidae) and Ceratitis capitata (Diptera: tephridae). J Invertebr Pathol 124:9095.
151. Cawoy H,, Mariuto M,, Henry G,, Fisher C,, Vasileva C,, Thonart N,, Dommes J,, Ongena M. 2014. Plant defence stimulation by natural isolates of Bacilllus depends on efficient surfactin production. Mol Plant Microbe Interact 27:87100.
152. Teixiera L,, Ferreira A,, Ashburner M. 2008. The bacterial symbiont Wolbachia induces resistance to RNA viral infections in Drosophila melanogaster. PLoS Biol 6:27532763.
153. Iturbe-Ormaetxe I,, Walker T,, Neill SLO. 2011. Wolbachia and the biological control of mosquito-borne disease. EMBO Rep 12:508518.
154. Hoffmann AA,, Montgomery BL,, Popovici J,, Iturbe-Ormaetxe I,, Johnson PH,, Muzzi F,, Greenfield M,, Durkan M,, Leong YS,, Dong YX. 2011. Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission. Nature 476:454457.
155. Fenton A,, Johnson KN,, Brownlie JC,, Hurst GDD. 2011. Solving Wolbachia paradox: modeling the tripartite interaction between host, Wolbachia and a natural enemy. Am Nat 178:333342.
156. Vavre F,, Charlat S. 2012. Making (good) use of Wolbachia: what the model says. Curr Opin Microbiol 15:263268.
157. Caragata EP,, Dutra HLC,, Moreira LA. 2016. Exploiting intimate relationships: controlling mosquito-transmitted disease with Wolbachia. Trends Parasitol 32:207218.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error